---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000585"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T19:31:53.975921+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lipella Pharma enters $2.64M ATM equity facility with H.C. Wainwright

## Summary
- ATM agreement for up to $2,641,881 of common stock at market prices.
- H.C. Wainwright receives 3.0% cash commission on gross proceeds.
- Proceeds will be used for working capital and general corporate purposes.
- Shares offered under existing effective S-3 shelf registration.
- No obligation to sell; company may suspend or terminate at any time.

## SEC filing metadata
- accession: 0001753926-25-000585
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000585/0001753926-25-000585-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000585/g084763_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000585
- JSON: https://secwatch.observer/filing/0001753926-25-000585.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000585.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.